Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Wound care biologics industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Wound type trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Wound Care Biologics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising incidences of burn injuries in developing and underdeveloped regions
3.3.1.2. Increasing geriatric population globally
3.3.1.3. Innovations in wound care biologics in North America
3.3.1.4. Government initiatives regarding wound care treatment in Europe and North America
3.3.2. Industry pitfalls and challenges
3.3.2.1. High cost of wound treatment
3.3.2.2. Lack of trained physicians in underdeveloped economies
3.4. Regulatory landscape
3.5. Growth potential analysis
3.5.1. By product
3.5.2. By wound type
3.5.3. By end-use
3.6. Competitive landscape, 2018
3.6.1. Strategy dashboard
3.7. Porter’s analysis
3.8. PESTEL analysis
Chapter 4. Wound Care Biologics Market, By Product
4.1. Key segment trends
4.2. Skin substitutes
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.2.2. Biological
4.2.2.1. Market size, by region, 2014-2025 (USD Million)
4.2.2.2. Allograft
4.2.2.2.1. Market size, by region, 2014-2025 (USD Million)
4.2.2.3. Xenograft
4.2.2.3.1. Market size, by region, 2014-2025 (USD Million)
4.2.2.4. Others
4.2.2.4.1. Market size, by region, 2014-2025 (USD Million)
4.2.3. Synthetic
4.2.3.1. Market size, by region, 2014-2025 (USD Million)
4.3. Topical agents
4.3.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Wound Care Biologics Market, By Wound Type
5.1. Key segment trends
5.2. Diabetic foot ulcers
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. Venous leg ulcers
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. Pressure ulcers
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5. Surgical wounds
5.5.1. Market size, by region, 2014-2025 (USD Million)
5.6. Burns
5.6.1. Market size, by region, 2014-2025 (USD Million)
5.7. Others
5.7.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Wound Care Biologics Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Ambulatory surgical centers
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Others
6.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 7. Wound Care Biologics Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country, 2014 - 2025 (USD Million)
7.2.2. Market size, by product, 2014 - 2025 (USD Million)
7.2.3. Market size, by wound type, 2014 – 2025 (USD Million)
7.2.4. Market size, by end-use, 2014 – 2025 (USD Million)
7.2.5. U.S.
7.2.5.1. Market size, by product, 2014 – 2025 (USD Million)
7.2.5.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.2.5.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.2.6. Canada
7.2.6.1. Market size, by product, 2014 – 2025 (USD Million)
7.2.6.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.2.6.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.3. Europe
7.3.1. Market size, by country, 2014 - 2025 (USD Million)
7.3.2. Market size, by product, 2014 - 2025 (USD Million)
7.3.3. Market size, by wound type, 2014 – 2025 (USD Million)
7.3.4. Market size, by end-use, 2014 – 2025 (USD Million)
7.3.5. Germany
7.3.5.1. Market size, by product, 2014 – 2025 (USD Million)
7.3.5.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.3.5.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.3.6. France
7.3.6.1. Market size, by product, 2014 – 2025 (USD Million)
7.3.6.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.3.6.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.3.7. UK
7.3.7.1. Market size, by product, 2014 – 2025 (USD Million)
7.3.7.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.3.7.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.3.8. Italy
7.3.8.1. Market size, by product, 2014 – 2025 (USD Million)
7.3.8.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.3.8.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.3.9. Spain
7.3.9.1. Market size, by product, 2014 – 2025 (USD Million)
7.3.9.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.3.9.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.4. Asia Pacific
7.4.1. Market size, by country, 2014 - 2025 (USD Million)
7.4.2. Market size, by product, 2014 - 2025 (USD Million)
7.4.3. Market size, by wound type, 2014 – 2025 (USD Million)
7.4.4. Market size, by end-use, 2014 – 2025 (USD Million)
7.4.5. China
7.4.5.1. Market size, by product, 2014 – 2025 (USD Million)
7.4.5.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.4.5.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.4.6. Japan
7.4.6.1. Market size, by product, 2014 – 2025 (USD Million)
7.4.6.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.4.6.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.4.7. India
7.4.7.1. Market size, by product, 2014 – 2025 (USD Million)
7.4.7.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.4.7.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.4.8. Australia
7.4.8.1. Market size, by product, 2014 – 2025 (USD Million)
7.4.8.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.4.8.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.4.9. South Korea
7.4.9.1. Market size, by product, 2014 – 2025 (USD Million)
7.4.9.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.4.9.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.5. Latin America
7.5.1. Market size, by country, 2014 - 2025 (USD Million)
7.5.2. Market size, by product, 2014 - 2025 (USD Million)
7.5.3. Market size, by wound type, 2014 – 2025 (USD Million)
7.5.4. Market size, by end-use, 2014 – 2025 (USD Million)
7.5.5. Brazil
7.5.5.1. Market size, by product, 2014 – 2025 (USD Million)
7.5.5.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.5.5.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.5.6. Mexico
7.5.6.1. Market size, by product, 2014 – 2025 (USD Million)
7.5.6.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.5.6.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.5.7. Argentina
7.5.7.1. Market size, by product, 2014 – 2025 (USD Million)
7.5.7.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.5.7.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.6. MEA
7.6.1. Market size, by country, 2014 - 2025 (USD Million)
7.6.2. Market size, by product, 2014 - 2025 (USD Million)
7.6.3. Market size, by wound type, 2014 – 2025 (USD Million)
7.6.4. Market size, by end-use, 2014 – 2025 (USD Million)
7.6.5. South Africa
7.6.5.1. Market size, by product, 2014 – 2025 (USD Million)
7.6.5.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.6.5.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.6.6. Saudi Arabia
7.6.6.1. Market size, by product, 2014 – 2025 (USD Million)
7.6.6.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.6.6.3. Market size, by end-use, 2014 – 2025 (USD Million)
7.6.7. UAE
7.6.7.1. Market size, by product, 2014 – 2025 (USD Million)
7.6.7.2. Market size, by wound type, 2014 – 2025 (USD Million)
7.6.7.3. Market size, by end-use, 2014 – 2025 (USD Million)
Chapter 8. Company Profiles
8.1. Amnio Technology
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Derma Sciences
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Integra Life Sciences
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Kerecis
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. Mimedx Group
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Mölnlycke Health Care AB
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Osiris Therapeutics
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Smith & Nephew
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Solsys Medica
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Skye Biologics
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. Wright Medical
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
